Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Influenza Vaccination in Immunocompromized Patients

This study has been completed.
Boehringer Ingelheim
Merck Sharp & Dohme Corp.
Solvay Pharmaceuticals
Information provided by:
University Hospital Inselspital, Berne Identifier:
First received: October 30, 2008
Last updated: October 31, 2008
Last verified: October 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2008
  Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):